Zynex ranked 15th in revenue growth by Deloitte Tech Fast 500

By: InnovatioNews Monday November 18, 2013 0 comments Tags: Lone Tree, Thomas Sandgaard, Zynex

LONE TREE - Zynex Inc. (OTCQB: ZYXI)), a provider of non-invasive medical devices for electrotherapy and stroke rehabilitation, neurological diagnosis and cardiac monitoring, today announced it has been ranked 15^th in revenue growth among all medical device companies in the U.S. and Canada.

The ranking was made by Deloitte's 2013 Technology Fast 500. The company was ranked 335^th for revenue growth between 2008 and 2012 across all companies in North America.

During that period, Zynex's revenue grew 237 percent with 2012 revenue reaching $39.7 million. The Deloitte list also noted Zynex as the No.1 fastest-growing medical device company in Colorado.

The complete Deloitte 2013 Technology Fast 500 list can be found at www.fast500.com.

"It is an honor to be recognized this year by Deloitte's Technology Fast 500 for revenue growth for the fourth year in a row," said Thomas Sandgaard, Zynex founder and CEO.

"This award truly reflects the strong commitment of the Zynex team and gives me an opportunity to thank everyone here for their dedication and hard work."

Zynex, founded in 1996, operates under three primary business segments: Zynex Medical, Zynex NeuroDiagnostics and Zynex Monitoring Solutions.